Quarterly results round-up: Alere and Hologic make a loss, bioMérieux "in line"
This article was originally published in Clinica
Executive Summary
Diagnostics specialist Alere has seen 15% revenue growth during its first fiscal quarter, at $671.1m, but swung to a net loss of $4.1m, partly due to charges related to its acquisitions of IVD firm Axis-Shield and diabetes products supplier Arriva Medical.